Fulgent Genetics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Fulgent Genetics, Inc. now
Current reporting with the operating signal separated from the noise.
Fulgent Genetics, Inc. (FLGT) reports Q2 loss, misses revenue estimates
Investors are testing whether Fulgent Genetics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Investors are testing whether Fulgent Genetics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2022 Earnings Call Transcript
Investors are testing whether Fulgent Genetics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.INVESTOR NOTICE: Investors in Fulgent Genetics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – FLGT
The story matters when it changes Fulgent Genetics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Fulgent Genetics, Inc. Investor Alert: Robbins LLP Informs Shareholders of Class Action Against Fulgent Genetics, Inc. (FLGT)
Investors are testing whether Fulgent Genetics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q4 2020 Results
The story matters when it changes Fulgent Genetics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest FLGT filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Fulgent Genetics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →